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ORIGINAL ARTICLE
Words Fail Me: The Verbal IQ Deﬁcit in Inﬂammatory Bowel
Disease and Irritable Bowel Syndrome
Christine P. Dancey, PhD,* Elizabeth A. Attree, BSc,* George Stuart, PhD,† Christine Wilson, BSc,* and
Amanda Sonnet, BSc*
Background: Many chronic illnesses are accompanied by im-
paired cognitive functioning. In people with Inﬂammatory Bowel
Disease (IBD), there is some research to suggest a decrement in
verbal IQ (VIQ), when compared to people with Irritable Bowel
Syndrome (IBS) and healthy controls. Although this is an important
ﬁnding, it is necessary to ensure that such deﬁcits are not due to
methodological problems such as the failure to take into account
pre-morbid functioning.
Methods: A total of 88 people (IBD, N  29; IBS, N  29;
Controls, N  30) completed the Wechsler Abbreviated Scale of
Intelligence (WASI), the Wechsler Test of Adult Reading (WATR),
the Trait Rumination Questionnaire (TRQ), the Center for Epidemi-
ologic Studies Depression Scale (CES-D), and the General Health
Questionnaire (GHQ-12).
Results: We found evidence of a VIQ decrement in both IBD and
IBS groups when measured against both healthy controls and against
their own pre-morbid IQ scores (WTAR-Predicted WAIS-III IQ
measures). However, the decrement was larger (and of clinical
signiﬁcance) in the IBD group but not in the IBS group.
Conclusion: Some tentative evidence is presented which suggests
that poor VIQ performance may be due in part to interference from
excessive rumination.
(Inﬂamm Bowel Dis 2009;15:852–857)
Key Words: IBD, IBS, neuropsychological function, IQ, anxiety,
rumination, illness
Many chronic illnesses are accompanied by impairedcognitive functioning, eg, multiple sclerosis,1,2 sickle
cell disease,3 chronic kidney disease,4 type 2 diabetes melli-
tus,5 and inﬂammatory bowel disease (IBD).6 However, cog-
nitive impairment is also evident in chronic illnesses in which
no clear disease process has been identiﬁed, for example
chronic fatigue syndrome7,8 and irritable bowel syndrome
(IBS).6 The nature, quality, and quantity of deﬁcits found
depend on the type of illness studied and the instruments used
to investigate cognitive function. For example, whereas mul-
tiple sclerosis is sometimes accompanied by a working mem-
ory deﬁcit9,10 and accuracy and speed in everyday activities,11
it is IQ and attentional memory that are more often impaired
in sickle cell disease.12,13 Information processing speed may
be reduced in people with diabetes,5 people with chronic
fatigue syndrome,8 and in those with systemic lupus erythem-
atosus,14 while hepatitis C sufferers may experience problems
with sustained attention and psychomotor speed.15 Finally,
verbal IQ deﬁcits have been found in people with IBD and
IBS,6 while mild verbal memory deﬁcits have been reported
in patients with Lyme disease.16 While depression and med-
ication are potential protagonists in inﬂuencing neuropsycho-
logical performance,7,17 cognitive deﬁcits have nevertheless
been found in studies that have controlled for these factors,
eg, in studies investigating IBD.6,18 Clearly, there is the need
for a cognitive-based account of such dysfunction. Among
populations with multiple sclerosis and chronic fatigue syn-
drome, such problems have been attributed to impaired cog-
nitive processing19 or limited cognitive resources.20,21 The
latter argument ﬁnds support in the work of Blomhoff et al,22
who showed that people with IBS make increased use of
attentional resources. Similarly, Matotek et al9 argued that
verbal ﬂuency problems in people with multiple sclerosis
may also be due to capacity limitations in working memory.
The ﬁndings reported by Attree et al6 are an important
contribution to our understanding of the cognitive effects of
chronic illness. However, there are a number of methodolog-
ical issues that need to be addressed in order to make ﬁrmer
foundations on which to build our understanding. Speciﬁ-
cally, Attree et al did not report premorbid measures of IQ
that might otherwise be used to strengthen the case for
cognitive deﬁcits in these groups. Furthermore, they did not
report the extent to which the deﬁcit in verbal IQ was clini-
cally signiﬁcant. In the study that follows, we address both
these questions. However, we also take the opportunity to
speculate on a possible cause of the reduced verbal ﬂuency,
namely rumination. Scott and McIntosh23 suggested that ru-
mination uses cognitive resources in a way that necessarily
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results in a decrement in cognitive performance and it is on
this basis that we hypothesize that many of the cognitive
impairments reported above are a direct consequence of ru-
mination. In particular, we investigate the possibility that the
impairment in verbal ﬂuency in IBS reported by Attree et al6
is due to excessive rumination, and so in the remainder of this
introduction we examine the available evidence in support of
this hypothesis.
The ﬁnding that people with chronic illness ruminate is
well documented, as are its psychophysical effects. For ex-
ample, Sullivan et al24 showed that pain-rumination was the
strongest predictor of perceived pain and disability among
patients with soft-tissue injuries. Devoulyte and Sullivan25
showed that people with upper respiratory tract illness also
ruminate about their pain, and that this variable shows the
strongest relationship with illness severity, even when con-
trolling for initial symptom severity, duration of prior symp-
toms, and depression. In more direct support of our hypoth-
esis, rumination has also been shown to affect cognitive
processing: for example, there is a wealth of evidence show-
ing that pain, or even the threat of pain, disrupts attentional
processes.26,27
Whereas IBD is a rare organic disease with a clear
medical pathology, IBS is a more common functional disor-
der with no clear cause and no lasting effective treatment.
Although they have different etiologies, the conditions nev-
ertheless have some symptom overlap and so IBS and IBD
are often used as matched controls for one another. Rumina-
tion is very often related to a generalized anxiety associated
with worries and concerns about an illness, particularly in
people with chronic functional illness. Moreover, according
to Brosschot and Thayer,28 most patients suffering from med-
ically unexplained somatic complaints spend a great deal of
time worrying about their condition and therefore we expect
to ﬁnd higher levels of rumination in sufferers of IBS than
IBD. In the following experiment we further investigated the
possibility that the deﬁcit found in verbal IQ6 may be attrib-




A total of 88 volunteers participated in the study (see
Table 1 for full participant details). All participants met the
inclusion criteria (people with IBD or IBS with an illness
duration of at least 1 year, diagnosed by a qualiﬁed medical
practitioner). None of the volunteers (illness or control
groups) were suffering from a comorbid illness nor were they
taking any psychoactive medication. Institutional ethical
guidelines were followed and informed consent was obtained
from all participants. People with IBD and IBS were recruited
from a database that consisted of research-volunteers and also
from local community-media notices. As an additional con-
trol, members of the healthy group were recruited from
friends and relatives of the IBD and IBS participants. There
were no statistical differences in mean age or years of edu-
cation between the 3 groups.
Measures
Each participant completed 2 types of cognitive-func-
tion assessment (described below) as well as completing a
series of depression, rumination, and anxiety scales (details
also given below). All testing took place in the participants’
homes and assessments were administered in a random order
and executed according to the published instructions.
Neuropsychological Tests
The Wechsler Abbreviated Scale of Intelligence
(WASI) was used to assess the participants’ verbal, nonverbal
and general cognitive functioning. The WASI was developed
to ensure that the 4 subtest items in this test battery have
TABLE 1. Means, Standard Errors, F, and P-values for ANOVA on Demographic and Psychosocial Variables
Variable
IBS (n29) IBD (n29) Healthy (n30)
Overall
Comparison
M SE M SE M SE F P
Age 45 2.80 45 3.33 39 3.31 1.43 0.25
Years of education 12.2 .39 11.7 .36 12.3 .38 .87 0.42
Anxiety 15.10 .79 14.7 .71 12.5 .66 3.76 0.03
Depression 38.69 2.44 40.00 2.39 34.37 1.87 1.75 0.18
TRQ 33.31 1.30 31.03 1.38 32.01 1.47 .70 0.50
Motivation 10.03 .83 7.55 .91 7.83 .77 2.62 0.08
Distraction 10.41 .64 11.65 .83 11.33 .78 7.17 0.49
Emotion 12.86 .91 11.82 .77 12.33 .75 4.20 0.66
Years of illness 10.05 1.81 13.52 2.19 — — 1.49 0.23
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different but parallel forms to the Wechsler full-scale coun-
terparts, thus the Verbal IQ, Performance IQ, and Full Scale
IQ scores obtained from the WASI are linked to the Wechsler
Adult Intelligence Scale (WAIS), Third Edition.29
Premorbid intellectual functioning was assessed by the
Wechsler Test of Adult Reading (WTAR), UK Adaptation.29
The WTAR is an assessment tool for estimating premorbid
intellectual functioning of adults ages 16–89. This reading
test comprises 50 words that have atypical grapheme to
phoneme translations, which means that the participant is
unlikely to be able to pronounce the words using previous
learning. The rationale for using this test is:
“Unlike many intellectual and memory abilities, read-
ing recognition is relatively stable in the presence of cogni-
tive declines associated with normal aging or brain injury.
The purpose of the WTARUK is not for the assessment and
diagnosis of developmental reading disorders, but rather for
an initial estimation of pre-morbid intellectual and memory
abilities (assuming a normal development of reading skills
prior to injury or cognitive decline)” (WTAR manual, p 2).29
In order to summarize performance in terms of actual
and WTAR-predicted WAIS-III scores, the participants’ ages
were needed in order to use the correct norms table given in
the WTAR manual. The WTAR raw scores were converted to
standard scores by means of the norms table. For instance, if
the WTAR raw score was 30, for 16–24-year-olds, the stan-
dard score equivalent would be 94, whereas for 80–89-year-
olds, the standard score would be 90.
Predicted VIQ and Observed VIQ Difference
This involved simply subtracting the observed VIQ
scores from the predicted VIQ scores. The procedure in-
volves comparison of actual difference scores with the ex-
pected difference score given in the WTAR manual. For each
participant the actual difference score is compared with a
minimum critical difference score necessary for statistical
signiﬁcance at a criterion level of P  0.15 or P  0.05 (see
WTAR manual, p 272).29 We used the more stringent P
 0.05 criterion level. Further details of the WTAR are given
in the WTAR Manual.29
WTAR-Predicted WAIS-III Full IQ (FIQ), Performance
IQ (PIQ), and VIQ
These scores were calculated by using tables given in
the WTAR manual, using demographic and the WTAR
scores to give the correct WTAR-predicted WAIS-III IQ
values.
Scores in the text are reported as either observed-VIQ,
as measured by the WASI or predicted-VIQ scores, as mea-
sured by the WTAR (WTAR-predicted WAIS-III VIQ). In
the analyses of covariance carried out the data were analyzed
with illness group (IBD versus IBS versus healthy) and type
of VIQ score (observed VIQ versus predicted VIQ) as the
between-participants and repeated measures variables, re-
spectively. The covariates were age, sex, years of education,
and anxiety.
Assessment of Rumination
The Trait Rumination Questionnaire (TRQ)23 was used
to measure participants’ tendency to ruminate across sub-
scales of emotionality, motivation, and distraction. Responses
are on a 7-point Likert scale, which ranges from “does not
describe me well” to “does describe me well.”
Assessment of Depression
The Center for Epidemiologic Studies Depression
Scale30 is a 20-item self-report scale designed to measure
depressive symptomatology in the general population. Re-
sponses are on a 4-point Likert scale. This scale was designed
to measure current level of depressive symptomatology, with
emphasis on the affective component, depressed mood.
Assessment of Anxiety
A shortened version of the General Health Question-
naire (GHQ-1231 was used as a measure of anxiety. The
questionnaire comprises 12 questions, and asked participants
about their general level of happiness, experience of depres-
sive and anxiety symptoms, and sleep disturbance over the
last 4 weeks. Interpretation of the answers was based on a
4-point Likert response scale (symptom present: “not at all”
 0, “same as usual”  1, “more than usual”  2 and “much
more than usual”  3).
RESULTS
A 1-way ANOVA was carried out on the demographic
and psychosocial variables. Since there was a signiﬁcant
difference in anxiety level between the groups, a post-hoc test
using Tukey’s HSD was carried out. It emerged that people
with IBS were signiﬁcantly more anxious than healthy con-
trols (P  0.034). Comparisons between the illness groups
(IBS versus IBD) and between healthy controls and the IBD
group were nonsigniﬁcant (P  0.900 and P  0.092, re-
spectively). None of the other demographic or psychosocial
variables were signiﬁcantly different between the groups (see
Table 1).
Although neither of the main effects was signiﬁcant,
there was a strong interaction between illness group and type
of VIQ (observed VIQ versus predicted VIQ), F(2,81)
 13.14, P  0.001, Eta2  0.245 (see Fig. 1). Although the
groups differed very little in their predicted VIQ scores, the
observed VIQ scores showed a large difference between
groups: While healthy controls scored higher than predicted,
the illness groups showed a strong decrement in observed
VIQ, both relative to the healthy control group (thus repli-
cating the pattern reported by Attree et al6) and relative to
their own predicted VIQ scores.
To gain further insight into this ﬁnding, we used the
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difference between the predicted VIQ and the observed VIQ
scores for each participant. The number of participants in
each group who showed a statistically signiﬁcant decrement
was counted. This led to a ﬁnding of 27 (93.1%), 22 (77.3%),
and 8 (27.3%) for IBD, IBS, and healthy controls, respec-
tively. However, it is debatable whether this equates to true
clinical signiﬁcance, since many participants who showed a
statistically signiﬁcant difference were in the normal range of
distribution for both PIQ and observed VIQ, and some were
quite high. We therefore took a more cautious approach in
deciding whether these statistically signiﬁcant decrements
were clinically signiﬁcant by setting a criterion level for
clinical signiﬁcance: individuals were considered to have an
unambiguous clinically signiﬁcant observed VIQ deﬁcit if
their PIQ scores were over 89 and their observed VIQ scores
were lower than 90; all of these individuals had at least a
10-point observed VIQ decrement. There were 15 partici-
pants who met this criterion. Of these, the majority (13; more
than 80%) were in the IBD group. In fact, only 1 healthy
comparison participant (3%) and 1 person with IBS (3%)
showed a clinically signiﬁcant deﬁcit.
The difference scores were then entered as the re-
peated measure in an ANCOVA in which illness group was
once again the independent factor and the covariates were
age, sex, years of education, and anxiety. We once again
found a strong interaction effect, F(2,81)  11.517, P
 0.001, Eta2  0.217. Although all 3 groups were similar
in terms of PIQ, the 2 illness groups (IBD and IBS)
showed a marked deﬁcit in observed VIQ relative to their
own PIQ. In the healthy comparison group, the PIQ and
observed VIQ were similar. These results, displayed in
Figure 2, are very similar to those reported by Attree et al6
even when the premorbid IQ (WTAR-predicted WAIS-III
FIQ) was taken into account.
Given that the observed VIQ score is composed of 2
component tests, vocabulary and similarities, it was of inter-
est to determine if just 1 or both of these tests added signif-
icantly to the overall observed VIQ decrement. To this end,
multiple regression was carried out using scores on the vo-
cabulary and similarities subtests as predictors. Only the
vocabulary subtest was found to be a signiﬁcant predictor of
the PIQ-observed VIQ difference score (b  0.40, beta
 0.36, t  2.81, P  0.007). The similarities subtest
showed no relationship with PIQ-observed VIQ (b  0.08,
beta  0.07, t  0.54, P  0.595).
Finally, we tested our hypothesis with regard to
rumination. The rumination data revealed an interesting,
although statistically nonsigniﬁcant pattern. In terms of the
effort that participants used to try to reduce rumination
(motivation subscale of the TRQ), IBS participants scored
more highly (10.0) than either the IBD (7.6) or control
(7.8) groups. This was supported by a strong, although
nevertheless nonsigniﬁcant main effect, F(2,85)  2.62, P
 0.08. For the other 2 measures of rumination, distraction
and emotion, there were no effects approaching signiﬁ-
cance, F(2,85)  0.717, P  0.49 and F(2, 85)  0.420, P
 0.66, respectively. A direct correlation between mea-
sures of rumination and observed VIQ for the groups
separately showed that for the IBD group the distraction
component of rumination negatively correlated with ob-
served VIQ (r  0.44; P  0.02) and for the IBS group
only the total of the rumination components correlated
with observed VIQ (r  0.37; P  0.05). There was no
signiﬁcant correlation between any of the rumination mea-
sures and observed VIQ for the control group.
FIGURE 1. Predicted Verbal IQ and observed Verbal IQ for all
groups.[Color ﬁgure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
FIGURE 2. Performance IQ and observed Verbal IQ for all
groups. [Color ﬁgure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
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DISCUSSION
The results of the present study conﬁrm Attree et al’s6
ﬁnding of a decrement in VIQ compared with PIQ in both
IBD and IBS participants. Moreover, the observed VIQ dec-
rement in these groups was found relative to both their own
PIQ and to the observed VIQ/PIQ scores of the control group.
It should be noted that in spite of the observed VIQ decre-
ment, the mean observed VIQ scores for both illness groups
were still within the normal range and therefore the decre-
ment cannot be seen as indicative of more general impair-
ment. However, this does not detract from the ﬁnding that
both illness groups showed a relative observed VIQ deﬁcit
that could not be predicted on the basis of predicted VIQ.
Whereas almost half of the IBD participants were shown to
have a signiﬁcant clinical decrement, only 1 participant in the
IBS group showed a clinical decrement.
It is interesting to note that of the 2 components of
observed VIQ, only the vocabulary subscale was able to
predict the PIQ-observed VIQ difference score. The observed
VIQ deﬁcit in the illness groups therefore seems to reﬂect
performance on the individual vocabulary subtest in particu-
lar. Whereas the similarities subtest assesses abstract verbal
reasoning, the vocabulary subtest determines the degree to
which a person has acquired, understood, and is able to
express vocabulary. Given that the predicted VIQ was normal
in both illness groups, we can assume that the problem lay
either in comprehension or expression, the most likely of
which would be verbal expression given the absence of any
observable neurological damage. So we must ask why IBD
and IBS patients might have a decrement in their verbal
expression abilities? Our own tentative hypothesis was that
illness groups, particularly the IBS group, would show a
higher propensity to ruminate about their illness. However,
we found that only motivation to reduce rumination (and not
distraction) was marginally different between the groups.
Given that the other measures of rumination were similar,
there is therefore circumstantial evidence for a higher level of
rumination among the IBS group, for which these participants
expend more cognitive effort in trying to reduce. However,
given the nature of the questionnaire the rumination in the
present context may have been directed toward performance
on the cognitive tasks, rather than illness-related.
The lack of signiﬁcant differences in rumination may in
part be attributed to the choice of instrument. We had pre-
dicted that IBS patients would suffer greater distraction from
ruminative thought; however, our selection of the TRQ was
useful in allowing us to measure motivation to overcome
rumination (something that would be expected among illness
groups who had not previously been predisposed to rumina-
tion) and this cognitive effort in itself may draw on limited
resources. On the other hand, the TRQ may not have been
sensitive enough to distinguish between the groups and so a
health-based rumination questionnaire may be useful in fu-
ture investigations of this kind. The ﬁnding that our rumina-
tion measure appeared to differentiate the 2 illness groups
from one another, rather than from the control group, adds
weight to the argument that different mechanisms underlie
the observed VIQ deﬁcit in the 2 types of illness, particularly
in the light of our ﬁnding that the IBD group was far more
likely to display clinical levels of observed VIQ deﬁcit,
whereas the IBS group remained within the normal range.
Moreover, the ﬁnding that rumination was correlated with
observed VIQ only in the illness groups, albeit in a complex
pattern, warrants further research. For now, we tentatively
suggest that, whereas observed VIQ deﬁcits in IBS patients
may have an underlying cognitive cause, those found in IBD
patients may have a more organic basis, as suggested by
Hollerbach et al.18 They found that 75% of the IBD group in
their study (n  24) showed short-term memory dysfunction
and focal white matter lesions. They concluded that the
disease process itself was responsible for these effects.
In summary, our main ﬁndings are of a strong and clear
observed VIQ decrement in people with IBD and IBS com-
pared to healthy controls that is unlikely to be due to pre-
morbid levels of intellectual functioning. Moreover, the dec-
rement is particularly strong for people with IBD. Although it
is clear that further assessments of neuropsychological func-
tioning, addressing the underlying causes of observed VIQ
decrement in IBD patients, are necessary, the present ﬁndings
have revealed further insights regarding the pattern of intel-
lectual functioning in people with IBD and people with IBS.
REFERENCES
1. Ghaffar O, Feinstein A. The neuropsychiatry of multiple sclerosis: a
review of recent developments. Curr Opin Psychiatry. 2007;20:278–
285.
2. Ryan KA, Rapport LJ, Sherman TE, et al. Predictors of subjective
well-being among individuals with multiple sclerosis. Clin Neuropsy-
chol. 2007;21:239–262.
3. Schatz J, Finke R, Roberts CW. Interactions of biomedical and environ-
mental risk factors for cognitive development: a preliminary study of
sickle cell disease. J Dev Behav Pediatr. 2004;25:303–310.
4. Thornton WL, Shapiro RJ, Deria S, et al. Differential impact of age on
verbal memory and executive functioning in chronic kidney disease.
J Int Neurospychol Soc. 2004;13:344–353.
5. Brands AMA, van den Berg E, Manschot SM, et al. A detailed proﬁle of
cognitive dysfunction with type 2 diabetes mellitus. J Int Neuropsychol
Soc. 2007;13:288–297.
6. Attree EA, Dancey CP, Keeling D, et al. Cognitive function in people
with chronic illness: inﬂammatory bowel disease and irritable bowel
syndrome. Appl Neuropsychol. 2003;10:96–104.
7. Lawie SM, MacHale SM, Cavanagh JTO, et al. The difference in
patterns of motor and cognitive function in chronic fatigue syndrome
and severe depressive illness. Psychol Med. 2000;30:433–442.
8. Cook DB, Nagelkirk PR, Perkerman A, et al. Exercise and cognitive
performance in chronic fatigue syndrome. Med Sci Sports Exerc. 2005;
31:1460–1467.
9. Matotek K, Saling MM, Gates P, et al. Subjective complaints, verbal
ﬂuency, and working memory in mild multiple sclerosis. Appl Neuro-
psychol. 2002;8:204–210.
10. Arango-Lasprilla JC, De Luca J, Chiaravalloti N. El perﬁl neuropsico-
lo´gico en la esclerosis multiple. Psicothema. 2007;19:1–6.
11. Goverover Y, Genova HM, Hillary FG, et al. The relationship between
Dancey et al Inﬂamm Bowel Dis ● Volume 15, Number 6, June 2009
856
neuropsychological measures and the timed instrumental activities of
daily living tasks in multiple sclerosis. Mult Scler. 2007;13:636–644.
12. Noll R, Stith L, Garstein M, et al. Neuropsychological functioning of
youths with sickle cell disease: comparison with non-chronically ill
peers. J Pediatr Psychol. 2001;26:69–78.
13. Wang W, Enos L, Gallagher D, et al. Neuropsychologic performance in
school-aged children with sickle cell disease: a report from the Coop-
erative Study of Sickle Cell Disease. J Pediatr. 2001;139:391–397.
14. Shucard JL, Parrish J, Shucard DW, et al. Working memory and pro-
cessing speed deﬁcits in systemic lupus erythematosus as measured by
the paced auditory serial addition test. J Int Neuropsychol Soc. 2004;
10:35–45.
15. Hilsabeck RC, Perry W, Hassenein TI. Neuropsychological impairment
in patients with chronic hepatitis C. Hepatology. 2003;35:440–446.
16. Westervelt HJ, McCaffrey RJ. Neuropsychological functioning in
chronic Lyme disease. Neuropsychol Rev. 2002;12:153–177.
17. Lichter I, Richardson PJ, Wyke MA. Diffential effects of atenolol and
enalapril on memory during treatment for essential hypertension. Br J
Clin Pharmacol. 1986;21:641–645.
18. Hollerbach S, Kullman F, Geissler A, et al. Impairment of short-term
memory function and morphological brain abnormalities in inﬂamma-
tory bowel disease. Gastroenterology. 2000;118:1723.
19. Hooﬁen D, Gilboa A, Vakil E, et al. Unawareness of cognitive deﬁcits
and daily functioning among persons with traumatic brain injuries.
J Clin Exp Neuropsychol. 2004;26:278–290.
20. Litvan I, Grafman J, Vendrell P, et al. Multiple memory deﬁcits in
patients with multiple sclerosis. Arch Neurol. 1988;45;607–611.
21. Marshall PS, Forstot BA, Callies A, et al. Cognitive slowing and
working memory difﬁculties in chronic fatigue syndrome. Psychosom
Med. 2004;59:58–66.
22. Blomhoff S, Spetelan S, Jacobsen MB, et al. Phobic anxiety changes the
function of the brain-gut axis in irritable brain syndrome. Psychosom
Med. 2001;63:959–965.
23. Scott VB Jr, McIntosh WD. The development of a trait measure of
ruminative thought. Pers Individ Differ. 1999;26:1045–1056.
24. Sullivan ML, Stanish W, Waite H, et al. Catastrophizing, pain and
disability in patients with soft-tissue injuries. Pain. 1988;77:253–
260.
25. Devoulyte K, Sullivan MJ. Pain catastrophizing and symptom severity
during upper respiratory tract illness. Clin J Pain. 2003;19:125–129.
26. Crombez G, Ecc1eston C, Baeyens F, et al. Attentional disruption is
enhanced by the threat of pain. Behav Res Ther. 1988;36:195–204.
27. Dick BD, Rashiq S. Disruption of attention and working memory traces
in individuals with chronic pain. Anesth Analg. 2007;104:1223–1229.
28. Brosschot JF, Thayer JF. Worry, perseverative thinking and health. In:
Biobehavioral Perspectives on Health and Disease. Vol. 6. London:
Harwood Academic; 2003.
29. Wechsler D. Wechsler Test of Adult Reading. San Antonio, TX: Psy-
chological Corporation; 2001.
30. Radloff LS. The CES-D scale. A self-report depression scale for re-
search in the general population. Appl Psychol Measure. 1977;1:385–
401.
31. Goldberg D. General Health Questionnaire (GHQ-12). Windsor, UK:
NFER-Nelson; 1992.
Inﬂamm Bowel Dis ● Volume 15, Number 6, June 2009 Verbal IQ Deﬁcit in IBD
857
